Literature DB >> 1531770

Changes in left ventricular mass with rejection after heart transplantation in infants.

M Kawauchi1, M M Boucek, S R Gundry, M S Kanakriyeh, J A de Begona, A J Razzouk, L L Bailey.   

Abstract

Thirty-three infants who underwent successful heart transplantation before 6 months of age were studied to evaluate subacute changes in left ventricular mass (LVM) and its correlation to a history of rejection episodes. LVM and left ventricular wall mass (LVWM) and their percentage of predicted normal values were analyzed by means of M-mode echocardiography. LVM (as a percentage of predicted normal for body surface area) at 1 week, 1 month, and 3 months after transplantation was 103.2% +/- 24.5%, 137.3% +/- 36.0%, and 138.6% +/- 32.0%, respectively. Values for the wall mass were 82.1% +/- 23.0%, 111.3% +/- 35.7%, and 104.6% +/- 30.4%. After 1 and 3 months, both LVM and LVWM were significantly (p less than 0.01) increased from the values in the first week. The patients were subdivided on the basis of a history of rejection. There were six patients without a rejection episode within 1 month (group 1), 17 patients with one rejection episode (group 2), and 10 patients with two or more episodes (group 3). LVM at 1 month was 104.5% +/- 27.7% for group 1, 142.5% +/- 27.7% for group 2 (p less than 0.05), and 148.9% +/- 31.3% for group 3 (p less than 0.05). LVWM at 1 month was 83.4% +/- 24.6%, 114.8% +/- 35.3%, and 122.2% +/- 36.2% (groups 1 through 3, respectively). Thus an increase in posttransplant LVM may signify a rejection episode. Heart transplantation in infancy increases LVM and LVWM (septum and posterior wall); the degree of thickening of septum correlates well with rejection episodes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531770

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

1.  Right Ventricular Dysfunction as an Echocardiographic Measure of Acute Rejection Following Heart Transplantation in Children.

Authors:  Sanjeev Aggarwal; Jennifer Blake; Swati Sehgal
Journal:  Pediatr Cardiol       Date:  2016-11-23       Impact factor: 1.655

2.  Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection.

Authors:  Irina A Ionova; Jeannette Vásquez-Vivar; Brian C Cooley; Ashwani K Khanna; Jennifer Whitsett; Anja Herrnreiter; Raymond Q Migrino; Zhi-Dong Ge; Kevin R Regner; Keith M Channon; Nicholas J Alp; Galen M Pieper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-23       Impact factor: 4.733

3.  Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.

Authors:  Galen M Pieper; Irina A Ionova; Brian C Cooley; Raymond Q Migrino; Ashwani K Khanna; Jennifer Whitsett; Jeannette Vásquez-Vivar
Journal:  J Pharmacol Exp Ther       Date:  2009-03-23       Impact factor: 4.030

4.  Speckle-tracking 2-dimensional strain echocardiography: a new noninvasive imaging tool to evaluate acute rejection in cardiac transplantation.

Authors:  Galen M Pieper; Akash Shah; Leanne Harmann; Brian C Cooley; Irina A Ionova; Raymond Q Migrino
Journal:  J Heart Lung Transplant       Date:  2010-05-20       Impact factor: 13.569

5.  Serial assessment of right ventricular function can detect acute cellular rejection in children with heart transplantation.

Authors:  Lindsay Arthur; Kenneth Knecht; Jennifer Ferry; Debby Grigsby; Horace Spencer; Dala Zakaria
Journal:  Pediatr Transplant       Date:  2022-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.